Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2000

View Archived Issues

Neurobiological Technologies and UC, Berkeley sign option agreement for CRF analogues

Designer transcription factor used to activate erythropoietin gene

Medarex and Athersys form therapeutic antibody partnership

Bayer and PPL Therapeutics to jointly develop aerosol AAT formulation

Schering-Plough receives extended marketing exclusivity, submits sNDAs for loratadine

Antex Biologics signs CRADA with U.S. Navy for Campylobacter vaccine

GlycoDesign and Leo Denmark form joint venture to develop cardiovascular drugs

Altea Genomics and Elan to jointly develop DNA vaccines

Novel lymphoma marker discovered using gene expression arrays

Ultrasound contrast agent deemed approvable by the FDA

Ilex and Millennium respond to FDA letter on Campath

Cel-Sci to commence phase II Multikine study in Czech Republic

FDA approves Azulfidine EN-tabs as treatment of juvenile RA

Antigenics to acquire Aquila Biopharmaceuticals

Serotonin antagonist improves drinking behavior in early-onset alcoholism

Cancer researchers reveal extended activity of tyrosine kinase inhibitor

Parke-Davis reports SAR of nonpeptide IL-8 receptor antagonists

Orally active nonpeptide NK1 antagonist selected by Fujisawa for clinical testing

PKC inhibitors under study at Kyowa Hakko

Advanced Medicine claims novel antibiotic compounds

New nonpeptide glucagon antagonists useful for hyperglycemia, etc.

Abbott discovers novel nonpeptidic antagonists of LFA-1/ICAM-1 interaction

Novel factor Xa inhibitors under development for thromboembolic disorders

AstraZeneca receives patent for new series of pyrimidine compounds

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...